IT1291134B1 - Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato - Google Patents
Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citratoInfo
- Publication number
- IT1291134B1 IT1291134B1 IT97RM000198A ITRM970198A IT1291134B1 IT 1291134 B1 IT1291134 B1 IT 1291134B1 IT 97RM000198 A IT97RM000198 A IT 97RM000198A IT RM970198 A ITRM970198 A IT RM970198A IT 1291134 B1 IT1291134 B1 IT 1291134B1
- Authority
- IT
- Italy
- Prior art keywords
- alcanoyl
- oral administration
- compositions suitable
- solid compositions
- magnesium citrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000198A IT1291134B1 (it) | 1997-04-08 | 1997-04-08 | Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato |
KR10-1999-7008940A KR100517680B1 (ko) | 1997-04-08 | 1998-03-19 | 알카노일-l-카르니틴 마그네슘 시트레이트를 함유하는 경구 투여용 고체 조성물 |
PCT/IT1998/000058 WO1998044918A1 (en) | 1997-04-08 | 1998-03-19 | Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
CA002285552A CA2285552C (en) | 1997-04-08 | 1998-03-19 | Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
AU67453/98A AU739522B2 (en) | 1997-04-08 | 1998-03-19 | Solid compositions suitable for oral administration comprising an alkanoyl-L-carnitine magnesium citrate |
JP54256498A JP4047936B2 (ja) | 1997-04-08 | 1998-03-19 | アルカノイル−l−カルニチンクエン酸マグネシウムを含有する経口投与に適した固体状組成物 |
EP98912693A EP0973515B1 (en) | 1997-04-08 | 1998-03-19 | Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
BRPI9808494-1A BR9808494B1 (pt) | 1997-04-08 | 1998-03-19 | sal de alcanoil-l-carnitina e composição compreendendo o mesmo. |
AT98912693T ATE230595T1 (de) | 1997-04-08 | 1998-03-19 | Feste zusammensetzungen, die alkanoyl-l-carnitin- magnesium-zitrat enthalten, zur oralen verabreichung |
ES98912693T ES2190069T3 (es) | 1997-04-08 | 1998-03-19 | Composiciones solidas apropiadas para la administracion por via oral que contienen un citrato de magnesio de alcanoilo-l-carnitina. |
SI9830353T SI0973515T1 (en) | 1997-04-08 | 1998-03-19 | Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
US09/381,730 US6337349B2 (en) | 1997-04-08 | 1998-03-19 | Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
NZ500532A NZ500532A (en) | 1997-04-08 | 1998-03-19 | Solid compositions suitable for oral administration comprising an alkanoyl-L-carnitine magnesium citrate |
DK98912693T DK0973515T3 (da) | 1997-04-08 | 1998-03-19 | Faste sammensætninger, der er egnet til oral indgivelse, hvilke sammensætninger omfatter et alkanoyl-L-carnitinmagnesiumcitrat |
DE69810601T DE69810601T2 (de) | 1997-04-08 | 1998-03-19 | Feste zusammensetzungen, die alkanoyl-l-carnitin-magnesium-zitrat enthalten, zur oralen verabreichung |
HK00102416A HK1025242A1 (en) | 1997-04-08 | 2000-04-20 | Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000198A IT1291134B1 (it) | 1997-04-08 | 1997-04-08 | Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM970198A1 ITRM970198A1 (it) | 1998-10-08 |
IT1291134B1 true IT1291134B1 (it) | 1998-12-29 |
Family
ID=11404949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT97RM000198A IT1291134B1 (it) | 1997-04-08 | 1997-04-08 | Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato |
Country Status (15)
Country | Link |
---|---|
US (1) | US6337349B2 (it) |
EP (1) | EP0973515B1 (it) |
JP (1) | JP4047936B2 (it) |
KR (1) | KR100517680B1 (it) |
AT (1) | ATE230595T1 (it) |
AU (1) | AU739522B2 (it) |
BR (1) | BR9808494B1 (it) |
CA (1) | CA2285552C (it) |
DE (1) | DE69810601T2 (it) |
DK (1) | DK0973515T3 (it) |
ES (1) | ES2190069T3 (it) |
HK (1) | HK1025242A1 (it) |
IT (1) | IT1291134B1 (it) |
NZ (1) | NZ500532A (it) |
WO (1) | WO1998044918A1 (it) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001289849A1 (en) * | 2000-08-29 | 2002-03-13 | Lonza A.G. | Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate |
ITRM20020055A1 (it) * | 2002-02-04 | 2003-08-04 | Aldo Fassi | Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
US7842726B2 (en) | 2005-09-30 | 2010-11-30 | Showa Denko K.K. | Carnitine derivative, salt thereof, external skin preparation and cosmetic material |
CN101209975B (zh) | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
US10646508B1 (en) | 2007-09-18 | 2020-05-12 | Thermolife International, Llc | Method of safely administering nitrate dietary supplements and compositions |
US10426750B1 (en) * | 2007-09-18 | 2019-10-01 | Thermolife International, Llc | Amino acid supplement formulations |
US10426792B1 (en) * | 2007-09-18 | 2019-10-01 | Thermolife International, Llc | Amino acid compositions |
US8466187B2 (en) | 2007-09-18 | 2013-06-18 | Thermolife International, Llc | Amino acid compositions |
US10435356B1 (en) * | 2007-09-18 | 2019-10-08 | Thermolife International, Llc | Amino acid compositions |
WO2010005465A1 (en) * | 2008-06-16 | 2010-01-14 | Scian Laboratories, Llc | L-carnitine and alkanoyl l-carnitine phytates and process for preparing the same |
US8802731B2 (en) | 2011-04-13 | 2014-08-12 | Thermolife International, Llc | N-acetyl beta alanine methods of use |
CN105777534B (zh) * | 2014-12-24 | 2018-07-06 | 辽宁科硕营养科技有限公司 | 柠檬酸钙盐及其制备方法与用途 |
US11865139B2 (en) | 2020-11-12 | 2024-01-09 | Thermolife International, Llc | Method of treating migraines and headaches |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1153640A (en) * | 1967-04-10 | 1969-05-29 | Soc D Etudes Prod Chimique | A Carnitin Salt |
FR2529545B1 (fr) * | 1982-07-02 | 1985-05-31 | Sanofi Sa | Nouveaux sels de carnitine ainsi que leur procede de preparation |
DE3463261D1 (en) * | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
CA2018137C (en) | 1989-06-14 | 2000-01-11 | Thomas Scholl | L-carnitine magnesium citrate |
US5073376A (en) | 1989-12-22 | 1991-12-17 | Lonza Ltd. | Preparations containing l-carnitine |
IT1261688B (it) * | 1993-05-28 | 1996-05-29 | Avantgarde Spa | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
EP0681839A3 (en) * | 1994-05-12 | 1997-11-12 | Hirohiko Kuratsune | A pharmaceutical preparation comprising an acylcarnitine |
-
1997
- 1997-04-08 IT IT97RM000198A patent/IT1291134B1/it active IP Right Grant
-
1998
- 1998-03-19 AU AU67453/98A patent/AU739522B2/en not_active Ceased
- 1998-03-19 ES ES98912693T patent/ES2190069T3/es not_active Expired - Lifetime
- 1998-03-19 JP JP54256498A patent/JP4047936B2/ja not_active Expired - Fee Related
- 1998-03-19 WO PCT/IT1998/000058 patent/WO1998044918A1/en active IP Right Grant
- 1998-03-19 KR KR10-1999-7008940A patent/KR100517680B1/ko not_active IP Right Cessation
- 1998-03-19 DK DK98912693T patent/DK0973515T3/da active
- 1998-03-19 EP EP98912693A patent/EP0973515B1/en not_active Expired - Lifetime
- 1998-03-19 NZ NZ500532A patent/NZ500532A/xx unknown
- 1998-03-19 DE DE69810601T patent/DE69810601T2/de not_active Expired - Lifetime
- 1998-03-19 CA CA002285552A patent/CA2285552C/en not_active Expired - Fee Related
- 1998-03-19 US US09/381,730 patent/US6337349B2/en not_active Expired - Fee Related
- 1998-03-19 AT AT98912693T patent/ATE230595T1/de not_active IP Right Cessation
- 1998-03-19 BR BRPI9808494-1A patent/BR9808494B1/pt not_active IP Right Cessation
-
2000
- 2000-04-20 HK HK00102416A patent/HK1025242A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69810601T2 (de) | 2003-08-07 |
EP0973515A1 (en) | 2000-01-26 |
US20010027214A1 (en) | 2001-10-04 |
HK1025242A1 (en) | 2000-11-10 |
KR100517680B1 (ko) | 2005-09-29 |
CA2285552A1 (en) | 1998-10-15 |
ITRM970198A1 (it) | 1998-10-08 |
US6337349B2 (en) | 2002-01-08 |
JP2001519804A (ja) | 2001-10-23 |
ES2190069T3 (es) | 2003-07-16 |
DK0973515T3 (da) | 2003-05-05 |
KR20010005864A (ko) | 2001-01-15 |
NZ500532A (en) | 2001-03-30 |
BR9808494A (pt) | 2000-05-23 |
JP4047936B2 (ja) | 2008-02-13 |
CA2285552C (en) | 2008-06-03 |
ATE230595T1 (de) | 2003-01-15 |
AU6745398A (en) | 1998-10-30 |
BR9808494B1 (pt) | 2009-05-05 |
WO1998044918A1 (en) | 1998-10-15 |
AU739522B2 (en) | 2001-10-11 |
EP0973515B1 (en) | 2003-01-08 |
DE69810601D1 (de) | 2003-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1291134B1 (it) | Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato | |
IT1290600B1 (it) | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato | |
IT1291133B1 (it) | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato | |
IT1291143B1 (it) | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina | |
IT1291126B1 (it) | Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine | |
IT1283086B1 (it) | Sali stabili e non igroscopici di l-carnitina e di alcanoil l-carnitine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |